Online pelvic health program for breast and gynecologic cancer survivors
A Pelvic Health eModule to Address Urogenital Impairments After Breast and Gynecologic Cancer: a Pilot Prospective Interventional Study
NA · Laval University · NCT06822582
This study is testing an online program to help breast and gynecologic cancer survivors improve their pelvic health and quality of life through group sessions with a physiotherapist.
Quick facts
| Phase | NA |
|---|---|
| Study type | Interventional |
| Enrollment | 20 (estimated) |
| Ages | 18 Years and up |
| Sex | Female |
| Sponsor | Laval University (other) |
| Drugs / interventions | chemotherapy, radiation |
| Locations | 2 sites (Edmonton, Alberta and 1 other locations) |
| Trial ID | NCT06822582 on ClinicalTrials.gov |
What this trial studies
The GYVE study tests an online program designed for individuals who have had breast or gynecologic cancer and are facing pelvic health issues such as urinary incontinence and sexual pain. This 12-week program includes weekly online group sessions led by a physiotherapist, focusing on pelvic floor muscle training, hydration, diet, and pain management. The study aims to evaluate the feasibility and acceptability of the program while exploring its preliminary effectiveness in reducing urogenital impairments. Participants will be recruited from Quebec and Edmonton, with the goal of providing valuable insights into the program's impact on quality of life for cancer survivors.
Who should consider this trial
Good fit: Ideal candidates are adults over 18 who have been diagnosed with breast or gynecologic cancer and are experiencing pelvic health dysfunction.
Not a fit: Patients without regular access to the internet or smart devices may not benefit from this online program.
Why it matters
Potential benefit: If successful, this program could significantly improve pelvic health and quality of life for cancer survivors experiencing related issues.
How similar studies have performed: While similar approaches have been explored, this specific online intervention for pelvic health in cancer survivors is relatively novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * be \>18 years of age; * have received a diagnosis of breast or gynecological (endometrial, cervical, ovarian, vulvar or vaginal) cancer (Stage I-IV) ; * be on active cancer treatment or have completed any cancer treatment (surgery and/or radiation therapy and/or chemotherapy) within the last 3 years; * be able to provide informed written consent in English or French; * have a urogenital dysfunction, as screened by a score of ≥ 2 on the Pelvic Floor Bother Questionnaire. Exclusion Criteria: * do not have regular access to internet, to a smart device or a computer, at home.
Where this trial is running
Edmonton, Alberta and 1 other locations
- University of Alberta — Edmonton, Alberta, Canada (RECRUITING)
- Centre interdisciplinaire de recherche en réadaptation et intégration sociale — Québec, Quebec, Canada (RECRUITING)
Study contacts
- Study coordinator: Stéphanie Bernard, Ph.D. PT
- Email: stephanie.bernard@fmed.ulaval.ca
- Phone: 418-529-9141
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Gynecologic Cancers, Breast Cancer Female, Incontinence, Incontinence Bowel, Sexual Dysfunction, Vaginal Atrophy, Sexual Dysfunction, Vaginal Dryness, Dyspareunia, Constipation, pelvic health